Understanding how EBV escapes the IRF7/IFN signaling pathway but retains IRF7's oncogenic activity is of great interest, as their outcomes shape not only the immune response to viral infection, but also affect aspects of host cell proliferation and survival. This evidence concerns the gene IRF7 and viral infectious disease.